期刊文献+

雷帕霉素对高糖诱导肾小球系膜细胞增生、肥大及细胞外基质合成的影响 被引量:2

Effect of rapamycin on hypertrophy of glomerular mesangial cells and extracellular matrix production induced by high glucose
暂未订购
导出
摘要 目的:观察雷帕霉素对高糖诱导肾小球系膜细胞增生、肥大及细胞外基质合成的影响。方法:在高糖状态下培养系膜细胞,予以不同剂量雷帕霉素进行干预,采用MTT的方法观察细胞增生能力,并用流式细胞仪检测各组系膜细胞体积,以前向角散射光平均强度表示细胞大小,Western印迹法检测细胞中纤维连接蛋白(FN)及Ⅳ型胶原(ColⅣ)的表达变化。结果:同正常糖及甘露醇组比较,高糖可使肾小球系膜细胞增生且发生肥大,同时高糖环境下系膜细胞分泌的FN及ColⅣ显著增加(P<0.05),而雷帕霉素能显著抑制高糖的上述作用(P<0.05),且呈剂量依赖性。结论:雷帕霉素可以抑制高糖状态下系膜细胞的增生、肥大及细胞外基质的合成,且呈剂量依赖性,有望用于糖尿病肾病的防治。 Objective:To observe the changes of extracellular matrix(ECM)production and hypertrophy of glomerular mesangial cells(GMC)induced by high glucose rats,and the inhibitory role of rapamycin.Methods: GMC cultured with high glucose,and different concentration of rapamycin.Cell proliferation rate was measured by MTT.The sizes of GMC were indicated by forward scatter intensity,measured by flow cytometery,and the levels of fibronection(FN) and collagen Ⅳ(Col Ⅳ) in the GMC were detected by Western blotting.Results: Compared with normal glucose group and osmotic control group,high glucose could induce GMC hypertrophy(P〈0.05).And the levels of FN,Col Ⅳ in GMC were higher in high glucose group than those in the other two groups(P〈0.05).Rapamycin could significantly dose dependently attenuated the GMC hypertrophy(P〈0.05),and lowered ECM production of cultured GMC(P〈0.05).Conclusion:High glucose can induce hypertrophy and ECM synthesis of GMC,which are significantly inhibited by rapamycin.Therefore,rapamycin may be used in the prevention and treatment of diabetic nephropathy.
出处 《中日友好医院学报》 2013年第4期227-230,共4页 Journal of China-Japan Friendship Hospital
基金 国家自然科学基金(81170675 81200537)
关键词 雷帕霉素 系膜细胞 高糖 细胞外基质 rapamycin mesangial cells high glucose extracellular matrix
  • 相关文献

参考文献15

  • 1Gnudi L,Thomas SM,Viberti G.Mechanical forces in diabet-ic kidney disease:a trigger for impaired glucose metabolism[J].J Am Soc Nephrol,2007,18(8):2226-2232.
  • 2Tahara A,Tsukada J,Tomura Y,et al.Effects of high glucoseon AVP-induced hypertrophy,and type IV collagen synthe-sis in cultured rat mesangial cells[J].Endocr Res,2012,37(4):216-227.
  • 3Li Zhuo,Bo Fu,Xueyuan Bai,et al.NAD blocks high glucoseinduced mesangial hypertrophy via activation of the Sirtu-ins-AMPK-mTOR pathway[J].Cellular Physiology and Bio-chemistry,2011,27(6):681-690.
  • 4Kolset SO,Reinholt FP,Jenssen T.Diabetic nephropathy andextracellular matrix[J].J Histochem Cytochem,2012,60(12):976-986.
  • 5Mariappan MM.Signaling mechanisms in the regulation ofrenal matrix metabolism in diabetes[J].Exp Diabetes Res,2012,2012:749812.
  • 6Wyczalkowska-Tomasik A,Bartlomiejczykl,Gornicka B,et al.Strong association between fibronectin accumulation andlowered cathepsin B activity in glomeruli of diabetic rats[J].J Physiol Pharmacol,2012,63(5):525-530.
  • 7Wang XT,Venkatraman S,Boey F,et al.Effects of con-trolled-released sirolimus from polymer matrices on humancoronary artery smooth muscle cells[J].J Biomater Sci PolymEd,2007,18(11):1401-1414.
  • 8Maeng M,Tilsted HH,Jensen LO,et al.3-Year clinical out-comes in the randomized SORT OUT III superiority trialcomparing zotarolimus-and sirolimus-eluting coronary stents[J].JACC Cardiovasc Interv,2012,5(8):812-818.
  • 9Khattab AA,Hamm CW,Senges J,et al.Incidence and pre-dictors of target vessel revascularization after sirolimus-elut-ing stent treatment for proximal left anterior descendingartery stenoses among 2274 patients from the prospectivemulticenter German Cypher Stent Registry[J].Clin Res Car-diol,2007,96(5):279-284.
  • 10Winbanks CE,Grimwood L,Gasser A,et al.Role of thephosphatidylinositol 3-kinase and mTOR pathways in theregulation of renal fibroblast function and differentiation[J].Int J Biochem Cell Biol,2007,39(1):206-219.

同被引文献60

  • 1Li J J, Kwak S J, Jung D S, et al. Podocyte biology in diabetic ne- phropathy [ J]. Kidney Int Supp1,2007 (106) :S36.
  • 2Yang Y, Wang J, Qin L, et al. Rapamycin prevents early steps of the development of diabetic nephropathy in rats [ J]. Am J Neph- ro1,2006,27 (5) :495.
  • 3Wang S,Zhou S,Min F,et al. roTOR-mediated hyperphosphoryla- tion of tau in the hippocampus is involved in cognitive deficits in streptozotocin-induced diabetic mice [ J ]. Metab Brain Dis, 2014,29 (3) :729.
  • 4Huber T B, Walz G, Kuehn E W. mTOR and rapamycin in the kidney : signaling and therapeutic implications beyond immunosup- pression [J]. Kidney Int,2011,79(5) :502.
  • 5Lu M K,Gong X G,Guan K L. mTOR in podocyte function [J]. Cell Cycle,2011,10(20) :3415.
  • 6Lieberthal W, Levine J S. Mammalian target of rapamycin and the kidney. I. The signaling pathway [J]. Am J Physiol Renal Phys- iol,2012,303( 1 ) :F1.
  • 7Mariappan M M. Signaling mechanisms in the regulation of renal matrix metabolism in diabetes [J]. Exp Diabetes Res,2012, 2012:749812.
  • 8Godel M, Hartleben B, Herbach N,et al. Role of mTOR in podo- cyte function and diabetic nephropathy in humans and mice [ J ]. J Clin Invest,2011,121 (6) :2197.
  • 9Lieberthal W,Levine J S. The role of the mammalian target of ra- pamycin(mTOR) in renal disease [ J]. J Am Soc Nephrol,2009, 20(12) :2493.
  • 10Brosius F C, Coward R J. Podocytes, signaling pathways, and vas- cular factors in diabetic kidney disease [ J]. Adv Chronic Kidney Dis,2014,21 (3) :304.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部